{
  "ticker": "CHD",
  "cik": "0000313927",
  "company_name": "CHURCH & DWIGHT CO INC /DE/",
  "filing_date": "2025-02-13",
  "item1_summary": " On October 28, 2021, the Board authorized a new share repurchase program, under which we may repurchase up to $1,000.0 in shares of Common Stock . The 2021 Share Repurchase Program does not have an expiration . The Board declared a 4% increase in the regular quarterly dividend from $0.295 per share, equivalent to an annual dividend of $1.18 per share .\n Cash, together with our current borrowing capacity, may be used for acquisitions that would complement our existing product lines or geographic markets . Share repurchase programs to the extent implemented by management, pay debt and interest as it comes due, pay dividends at the latest approved rate, and meet our capital expenditure program costs, which are expected to be approximately $130.0 in 2025 including manufacturing capacity investments for Therabreath and Sterimar .\n Cash conversion cycle at December 31, 2024 increased one day from the prior year . Net cash used in financing activities during the twelve months of 2024 was $343.4 reflecting $208.2 of net debt payments and $277.0 of cash dividend payments, partially offset by $14.0 for the Graphico acquisition .\n A group of four customers accounted for approximately 43% and 44% of consolidated net sales in 2024 and 2023 . A single customer (Walmart Inc. and its affiliates) accounts for approximately 23, 23% and 24% in 2024, 2023 and 2022, respectively . The Company will enter into interest rate lock agreements to hedge the risk of changes in interest payments attributable to changes in the interest rate associated with anticipated issuances of debt .\n This information appears under the heading “Market Risk” in the “Management’s Discussion and Analysis” section . Refer to page 50 of this Annual Report . Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles .\n Management evaluated the Company’s internal control over financial reporting as of December 31, 2024 . Deloitte & Touche LLP audited the internal control of the company's financial statements and financial statement schedule . The firm's opinions appear on pages 52 and 54 of this Annual Report on Form 10-K . The Board of Directors and Stockholders of Church & Dwight Co.\n In our opinion, the financial statements present fairly the financial position of the Company as of December 31, 2024 and 2023, in conformity with accounting principles generally accepted in the United States of America . We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting .\n The critical audit matter is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to audit committee . The communication of critical audit matters does not alter in any way our opinion on financial statements, taken as a whole, and we are not providing a separate opinion . The Company owns trade names that are considered to have indefinite lives .\n The Company's VITAFUSION and L’IL CRITTERS trade name was a full impairment of the $281.3 million trade name as of September 30, 2024 . The Company’s global WATERPIK business has continued to experience a decline in customer demand for many of its products, primarily due to lower consumer spending for discretionary products .\n Audit procedures related to the determination of revenue growth rates and the selection of discount rates for the trade names included the following, among others: We tested the effectiveness of controls over the account balance . We evaluated management’s ability to accurately forecast revenue growth by comparing actual performance to historical forecasts . We also evaluated the reasonableness of the forecasted revenue growth .\n The Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) eveloping a range of independent estimates and comparing those to the discount rates selected by management .\n Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles . We believe that our audit provides a reasonable basis for our opinion. ting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent .\n Internal control over financial reporting may not prevent or detect misstatements . Internal control may not provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements . Internal controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate .\n Income before income taxes, net of tax: $585.3-$585.6-$755.6-6,000-a-year . Net income per share: $1,057.4-1.5,000 . Net dividends per share - $1.68-1,000 per share . Net earnings per share from affiliates: $1.9-1 . Net interest, net income, net dividends, net interest and net interest . Net taxable income: $85,000/share; $585/share. Net income from affiliates .\n Church & DWIGHT CO., INC. reements reements  reements . reements (In millions, except share and per share data) see Notes to Consolidated Financial Statements. see  releases of the company's announcement of $1.2 billion in cash and cash equivalents. reement .\n Numerous current and long-term debts, current liabilities and stockholders' equity . Total Current Liabilities and Stockholders’ Equity at $2,878.2 billion . Total Stockholders' Equity at  $1.00 billion . See Notes to Consolidated Financial Statements for more information on the company's financial statements .\n Creditors' cash and operating expenses adjusted to reconcile net income to net cash provided by operating activities . Cash flow from operating activities adjusted to net income . Net income adjusted to reflect net cash flow from operations . Net earnings from unconsolidated affiliates adjusted to provide cash flow . Net net earnings of affiliates adjusted for non-cash compensation expense . Net assets and liabilities adjusted for changes in assets, liabilities and changes in value .\n The company's net cash flow from operating assets and liabilities is $1,030.6 billion . The net cost of the company has been $1.2 billion . Net cash flow is $2.8 billion, net interest is $3.3 billion . Cash flow from investing activities is $4.1 billion and net interest income is $6.9 billion .\n The amount of exchange rate changes on cash and cash equivalents is based on exchange rates . Cash and Cash Equivalents at Beginning of Period: $725.6-$730.6$730.4/730.5/730/730 . Cash paid during the year for:. Paid-in-capitalized interest (net of amounts capitalized) $1,000/1,500/2,000. Cash paid for::. Paid in cash, plant and equipment expenditures included in Accounts Payable (Paid in-capital)\n The Church &.wight Co. Inc. arnings are based on the value of a company's stock portfolio . The company's net income is $5,366.6 million . The Company's net value is $293.7 million . Inventors' net wealth is $1.2 billion . The firm's net worth is $3,489.3 million .\n      expense and stock option plan    transactions were transaction and stock purchases and dividends .  .  .   Expense and stock option plan receive compensation from expenses and stock option plan . Stock based compensation  referred to investment plan, receiving depends announcement and cash dividends .\n The Company, founded in 1846, develops, manufactures and markets a broad range of household, personal care and specialty products . The accompanying Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the U.S. (“US GAAP”) The Company also sells specialty products to industrial customers, livestock producers and through distributors .\n Management makes estimates regarding inventory valuation, promotional and sales returns reserves, the carrying amount of goodwill and other intangible assets, the realization of deferred tax assets, tax reserves and other matters that affect the reported amounts and other disclosures in the financial statements . Actual results could differ from those estimates, and it is possible that changes in such estimates could occur in the near term .\n The Company operates in Consumer Domestic, Consumer International and Specialty Products Division . The Consumer Domestic and Consumer International segments market a variety of personal care, household and over-the-counter products . The SPD segment focuses on sales to businesses and participates in Animal Nutrition, Specialty Chemicals and Commercial & Professional . The Company sells its specialty products to industrial customers, livestock producers and through distributors .\n For performance obligations related to the shipping and invoicing of products, control transfers at the point in time upon which finished goods are delivered to the Company’s customers . Once a product has been delivered or picked up by a customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset . The Company considers control to have transferred upon delivery or customer receipt .\n The Company excludes from its revenue any amounts collected from customers for sales (and similar) taxes . The Company entered into a factoring agreement with a financial institution to sell certain customer receivables at discounted rates in 2015 . Transactions under this agreement are accounted for as sales of accounts receivable and are removed from the Consolidated Balance Sheet at the time of the sales transaction .\n Church & DWIGHT CO., INC. and SUBSIDIARIES (Culprits) reported net sales of $1.2 billion in 2013 . Company's net sales are based on net sales, net profits, net sales and net operating costs . Unrealized gains and losses related to currency translation are recorded in Accumulated Other Comprehensive Income (Loss)\n The Company evaluates its inventory levels and expected usage on a periodic basis and records adjustments as required . The determination of whether inventory items are slow moving, obsolete or in excess of needs requires estimates and assumptions about the future demand for the Company’s products, technological changes, and new product introductions . Depreciation is recorded using the straight-line method over the estimated useful lives of the respective assets .\n The Company conducts annual reviews to identify idle and underutilized equipment, and reviews business plans for possible impairment . An indication of impairment occurs when the carrying value of the asset exceeds the future undiscounted cash flows . When an impairment is indicated, the estimated future cash flows are discounted to determine the estimated fair value .\n The Company determines whether an intangible asset (other than goodwill) has a useful life based on multiple factors, including how long the Company intends to generate cash flows from the asset . With respect to goodwill, impairment occurs when the carrying value of the reporting unit exceeds the discounted present value of cash flows for that reporting unit . Intangible assets with finite lives are amortized over their estimated useful lives .\n The Company incurred research and development expenses in the amount of $139.7.7, $.122.4 and $110.0 in 2024, 2023 and 2022 . Diluted EPS includes dilution from potential Common Stock issuable pursuant to the exercise of outstanding stock options . The fair value of stock-based compensation is determined at the grant date and the related expense is generally recognized over the required employee service period .\n The pre-tax expense associated with the fair value of stock awards is included in SG&A expenses and in cost of sales . Management provides a valuation allowance against deferred tax assets for amounts which are not considered ‘more likely than not’ to be realized . The Company records liabilities for potential assessments in various tax jurisdictions in accordance with GAAP .\n In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, Liabilities-Supplier Finance Programs (Topic 405-50): Disclosure of Supplier Finance Program Obligations . The amendments are effective for all entities for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years .\n In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures intended to improve reportable segment disclosure requirements . The Company has adopted the standard which resulted in additional disclosures. The Company is currently evaluating the impact of adoption on the Company’s related disclosures.\n The standard is effective for . annual reporting periods beginning after December 15, 2026, and interim periods beginning . after December . 15, with prospective or retrospective application permitted . The Company is currently evaluating the impact of adoption on the Company’s related disclosures . No other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact .\n The Company recognizes transfers between input levels as of the actual date of the event . The fair value of each class of financial ins. nstruments at December 31, 2024 and 2023 were used to estimate the fair value . There were no transfers between . input levels during the twelve months ended December 31 . 2024 .\n The Company determines the fair value of its senior notes based on their quoted market value or broker quotes, when possible . The carrying amounts of Accounts Receivable, Accounts Payable, and Accrued and Other Liabilities approximated estimated fair values as of December 31, 2024 and 2023 . The Company does not use derivatives for trading or speculative purposes .\n The Company reviews the effectiveness of its hedging instruments on a quarterly basis . If the Company determines that a derivative instrument is no longer effective in offsetting changes in fair values or cash flows, it recognizes the hedge ineffectiveness in current period earnings and discontinues hedge accounting with respect to the derivative instrument . The Company uses independent freight carriers to deliver its products .\n The Company has entered into hedge agreements with counterparties to mitigate the volatility of diesel fuel prices . The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, Pound, Euro, Mexican Peso, Chinese Yuan, Japanese Yen, and Australian Dollar. The Company entered into forward exchange contracts to reduce the impact of foreign exchange rate fluctuations related to anticipated but not yet committed sales or purchases .\n The Company entered into interest rate lock agreements to hedge the risk of changes in the interest payments attributable to changes in interest rates associated with anticipated issuances of debt . The net gain on the settlement of these interest rate locks agreements was included in Accumulated Other Comprehensive Income (Loss) The Company is subject to exposure due to the changes in prices of commodities used in production .\n The Company entered into equity derivative contracts covering its Common Stock in order to minimize its liability under its Executive Deferred Compensation Plan . The fair value of these commodity hedge agreements is reflected in the Consolidated Balance Sheet within Other Current Assets, Accounts Payable, and Accrued and Other Liabilities . The contracts are settled in cash .\n The fair values and amount of gain (loss) recognized in income and other comprehensive income associated with the derivative instruments disclosed above did not have a material impact on the Company’s consolidated financial statements for the periods ended December 31, 2024, 2023, and 2022 . Property, Plant and Equipment, Net (“PP&E”) consists of the following:. (‘P&E) (’) (1) in connection with the Vitamins, Minerals and Supplements (\"VMS\") impairment review completments)\n In the third quarter of 2024, the Company recorded an impairment charge of $60.0 in SG&A of Construction in progress assets . The charge was recorded in the Consumer Domestic segment . The Company acquired substantially all of the issued and outstanding shares of capital stock of Graphico, Inc. (\"Graphico\"), a Japan-based distributor focused on consumer goods primarily in the Japanese market .\n Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results . The goodwill and other intangible assets associated with the Graphico Acquisition are not deductible for U.S. tax purposes . The Hero Acquisition was financed with cash on hand and commercial paper borrowings and is managed in the Consumer Domestic segment .\n The Company has intangible assets of substantial value on its consolidated balance sheet . The goodwill and other intangible assets associated with the Hero Acquisition are not deductible for U.S. tax purposes . Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results .\n The following table provides information related to the carrying value of amortizable intangible assets . These intangible assets are more fully explained in the following sections . The following section provides an example of how the company intends to generate cash flows from the asset . The number of intangible assets with a useful life expectancy is based on the amount of time it takes to amortable intangible assets to carry on .\n The FINISHING TOUCH FLAWLESS assets consist of the definite-lived trade name, customer relationships and technology assets recorded at acquisition . The impairment charge relates to the VMS customer relationship intangible asset . The remaining net book value of the trade name as of December 31, 2024 is $15.4.4%- and will be amortized over a remaining useful life of .\n The estimated fair value of the intangible assets was determined using the income approach with Level 3 inputs . Fair value of indefinite-lived trade names was estimated based on a “relief from royalty” or “excess earnings” discounted cash flow method . The key assumptions used in determining fair value are sales growth, profitability margins, tax rates, discount rates and royalty rates .\n During the third quarter of 2024, the Company continued to experience a decline in market share and a deterioration in the financial performance of its VMS business, which includes the VITAFUSION and L'IL CRITTERS trade name . The continued decline in profitability caused management to reassess its long-term strategy and financial outlook of the business .\n The Company evaluated its ability to recover the carrying value of long-lived assets supporting the VMS business by comparing the carrying amount of those assets to the future undiscounted cash flows over the estimated life of the identified primary asset . The Company’s global WATERPIK business has continued to experience a significant decline in customer demand for many of its products .\n The WATERPIK business has experienced declining sales and profits resulting in a reduction in expected future cash flows . This indefinite-lived intangible asset may be susceptible to impairment . A continued decline in fair value could trigger a future impairment charge of the WATER PIK trade name . A favorable tariff ruling on certain Waterpik products imported from China .\n The Company’s annual goodwill impairment test, performed in the beginning of the second quarter of 2024, determined that the estimated fair value substantially exceeded the carrying values of all reporting units . The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment . Leases with an initial term of twelve months or less are not recorded on the consolidated balance sheet .\n For leases beginning in 2019, lease components (base rental costs) are accounted for separately from the nonlease components (e.g., common-area maintenance costs)  For leases that do not provide an implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments .\n Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item . Short-term lease expense is excluded from this amount and is not material . Leased assets obtained in exchange for new lease liabilities in 2024 consisted of $16.8 of real estate lease additions and $11.2 of equipment lease additions, net of modifications .\n The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows . The Company does not have an economic interest in the suppliers' receivables sales arrangements . In 2015, the Company initiated a Supply Chain Finance program (“SCF Program”). Qualifying suppliers may elect to sell their receivable from the Company for early payment .\n The Company's payment terms with suppliers are consistent between suppliers that elect to participate in the SCF Program and those that do not participate . Payments included in operating activities within the Company's Consolidated Statements of Cash Flows amounted to  $388388.7 and $395.1.1 in the years ended December 31, 2024 and 2023, respectively . The SCF program may allow suppliers to obtain more favorable terms than they could secure on their own .\n The Company may issue commercial paper notes up to an aggregate principal amount outstanding at any given time of $1,500 . The interest rates on the notes will vary based on market conditions and the ratings assigned to the notes by the rating agencies designated in the agreement at the time of issuance . The Company did not have any commercial paper outstanding as of December 31, 2024 or 20 .\n The Company entered into a $400.0-a-year unsecured term loan facility (as amended on June 16, 2022, the “Term Loan Facility”) The loan under the Term Loan Facility (the \"Term Loan\") was fully drawn at closing . The interest rate was the Secured Overnight Financing Rate (SOFR) plus a spread and an applicable margin based on the Company’s credit rating . The proceeds of the Loan were used to partially fund the TheraBreath acquisition, with the remaining proceeds used for the repayment of commercial paper .\n The 2027 Notes bear interest at ipient3.15% Senior Notes due 2027 (the \"2027 Notes\") The 2031 Notes are payable semi-annually, on each February 1 and August 1 . The 2032 Notes were used to repay commercial paper borrowings incurred to finance the Company’s acquisition of Hero Cosmetics, Inc.\n The Company issued $.5.00%-2052 Notes due 2052 (the 2052 Notes) In July 2022 a portion of the proceeds from the sale of the Notes were used to repay all of the Company's outstanding $.300.0%-2.45% Senior Notes due August 1, 2022 . The Company entered into a $1,500.0-a-year Credit Agreement providing for a revolving credit facility (the \"Revolving Credit Facility\")\n The following table summarizes the provision for U.S. federal, state and foreign income taxes . The current tax assets (liabilities) consist of the following at December 31, 2024 and 2023 . The deferred tax assets are expected to be at least $1.5 billion at the end of each year .\n The difference between tax expense and the tax that would result from the application of the federal statutory rate is as follows:  Tax expense and tax would be as follows . The difference is between tax expenses and tax rates that would be applied at the federal rate . The amount of deferred tax assets and liabilities will be determined at the end of the financial year .\n The Company believes it is more likely than not that the benefit from certain additional deferred tax assets of a foreign subsidiary will not be realized . Certain foreign subsidiaries of the Company had net operating loss carryforwards of approximately $.3.3 and $.9.0 . The Company maintains a valuation allowance of $.7.7 and $0.8.8 at December 31, 2024 and 2023, respectively .\n The Company believes that it is more likely than not that the benefit from the foreign tax credit carryforwards as of December 31, 2024 will not be realized . The Company has recorded liabilities in connection with uncertain tax positions, which, although supportable by the Company, may be challenged by tax authorities . A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:\n The Company is subject to U.S. federal income tax as well as income tax in multiple state and international jurisdictions . As of December 31, 2024, 2023, and 2022, the Company had accrued interest expense related to unrecognized tax benefits of $1.3.3%, $.9.9% and $.7% . The Company’s tax returns are closed for tax years through 2020 .\n The law did not have any material impacts on the Company's consolidated financial position, results of operations or cash flows during the year ended December 31, 2024 . The Company recognizes the grant-date fair value for each of these awards, less estimated forfeitures, as compensation expense ratably over the vesting period .\n Employee terminally terminated employee who meets the above conditions may exercise any stock options until the date such stock options otherwise would have expired, subject to specified conditions . Issuances of Common Stock to satisfy employee stock option exercises currently are made from treasury stock . Stock option transactions for the year ended December 31, 2024 were as follows:\n The following table summarizes information relating to options outstanding and exercisable as of December 31, 2024 . The table represents the Company’s estimate and estimate of the Company expectee of fully vested stock options fully vestedee . IARIES: (Continued) The Company expects a range of options outstanding, exercisable and prices for exercise options as of Dec. 31 2024 .\n The fair value of stock options is based upon the Black Scholes option pricing model . Expected forfeitures are not material and, therefore, are not reflected in the table above . The Company determined the stock options’ lives based on historical exercise behavior and their expected volatility and dividend yield . The risk-free interest rate is based on the yield of an applicable term Treasury instrument .\n The Company’s Consolidated Statements of Cash Flow reflect an add back related to stock option awards of $28.7.7%-$26.3%-$20.7% in 2024, 2023 and 2022, respectively, for non-cash compensation expense . The annual RSU grants vest one-third on each of the first, second and third anniversaries of the grant date, subject to the recipient's continued employment with the Company . The Company granted employees ipient120,080-pound RSUs with a total fair value of $10.4%-$102.40%- per RSU .\n In January 2021, the Company issued cash-settled stock units under the Omnibus Equity Plan to all employees at the level of vice president and below . These restricted stock units are scheduled to vest and be settled on the third anniversary of the date of grant, subject to continued employment through such date . The number of shares that may be issued ranges from ipient .\n The Company’s discounted Employee Stock Purchase Plan (“ESPP”) permits eligible employees to purchase Common Stock through after-tax payroll deductions . The maximum value of Common Stock that an eligible employee may purchase each calendar year is the lesser of 10% of their annual pay and $25,000 per year .\n The plan permits the Company to make profit sharing contributions that cannot otherwise be contributed to the qualified savings and profit-sharing plan due to limitations established by the Internal Revenue Service . The liability to plan participants for contributions designated for notional investment in Common Stock is based on the quoted fair value of the Common Stock plus any dividends credited . Each plan participant is fully vested in the amounts the participant defers .\n On October 28, 2021, the Board authorized a new share repurchase program, under which the Company may repurchase up to $1,000.0 in shares of Common Stock . The 2021 Share Repurchase Program does not have an expiration . In November 2023, the Company executed an agreement to purchase  3.3 million shares for $300.1 million shares .\n Tax benefit (expense) reclassified to consolidated statement of  income reclassified to consolidated statement of income-reclassed with reclassing income(a) December 31, 2022, 2022 and 2023, respectively,   Reclassified as taxable income (loss) before reclassifications Reclassified as a result of reclassification of taxable income .\n The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits . As of December 31, 2024, the Company had commitments of approximately $425.3.3 billion . The Company is not engaged in any other material transactions with the partnership or the partner supplier . In connection with the acquisition of the ZICAM® brand (the \"Zicam Acquisition\"), the Company deferred an additional cash payment of $20.0 billion .\n The Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements . The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract .\n The Company routinely enters into non-competition agreements for varying periods of time . Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition, results of operations and cash flows . Such proceedings are generally subject to considerable uncertainty and their outcomes, and any related damages, may not be reasonably predictable or estimable .\n The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division . The Company also has a Corporate segment . Revenues are derived from the sale of the following products: The Company's 50% interest in ArmaKleen was sold  to our joint venture partner in October 2024 .\n The Company’s equity in earnings of Armand and ArmaKleen, totaling $9.1, $8.7.7, and $.12.3, respectively, are included in the Corporate segment . The transaction is not material to the Company's results of operations or cash flows . The Chief Operating Decision Maker considers Operating Income for evaluating performance of each segment .\n Research and Development, general and administrative expenses, net sales and marketing expenses, Net Sales, net profits, net value, net earnings, net debt, net losses, net costs, net loss, net worth, net tax, net margin, net profit, net revenue, net income, net cost, net operating costs, operating costs and other expenses, and net value . Year Ended December 31, 2023 (1) and 2022)\n The increase in 2023 compared to 2022 is primarily due to higher incentive compensation costs . All costs for Research & Development administration, global compliance, technology support, packaging and sustainability are reported in the Consumer Domestic segment . Costs for Research and Development administration and global compliance support, . technology support and packaging and . sustainability are . reported in Consumer Domestic . segment .\n The accounting policies followed by each of the segments, including intersegment transactions, are substantially consistent with the accounting policies described in Note 1. ses for the period ended December 31, 2024 . Product line revenues from external customers were as follows: Revenues from external . customers for each . of the three years ended December . 31, 2022, 2024, 2023 and 2022 .\n Approximately    $. $.6,107.1.1% of the net sales reported in the accompanying consolidated financial statements in 2024, 2023 and 2022, respectively, were to customers in the U.S. $ $5,867.9% of long-lived assets were located in the United States at the end of the period covered by this Annual Report . No one country accounts for more than 20% of consolidated net sales and 5% of assets .\n The Company’s disclosure controls and procedures as of the end of the period covered by this Annual Report are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act are accurate . No change in internal control over financial reporting occurred during the Company‘s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's internal control of financial reporting .\n The information required by this item is incorporated in the Company’s definitive proxy statement, which will be filed with the Commission not later than 120 days after the close of the fiscal year covered by this Annual Report . The information is incorporated by reference to the information under the captions “Compensation Discussion and Analysis,” “2024 Summary Compensation Table” and “compensation & Human Capital Committee Report”\n The information required by this item is incorporated by reference to the information under the caption “Corporate Governance and other Board Matters – Board of Directors Independence” in the Company’s definitive proxy statement, which will be filed with the Commission not later than 120 days after the close of the fiscal year covered by this Annual Report . The following Consolidated Financial Statements are included in Item 8 of this Form 10-K .\n Unless otherwise noted, the file number for all the Company’s filings with the Securities and Exchange Commission referenced below is 1-10585 . For each of the three years in the period ended December 31, 2024,   Exhibits are Exhibit 3.1 to the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2020 .\n Church & Dwight Co. Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the 2.875% Notes due 2022, incorporated by reference to Exhibit 4.2 to the Company’s current report on Form 8-K filed on September 26, 2012 .\n Church & Dwight Co. Inc. and Deutsche Bank Trust Company Americas, as trustee, incorporated by reference to Exhibit 4.5 to the Company’s annual report on Form 10-K for the year ended December 31, 2019 .    -                         “Third Supplemental Indenture, dated as of November 2, 2022, between Church . & . Deutsche Bank Trust Co. Americas,  as trustee, and Deutsche . Bank of America, N.A., as . administrative agent .\n Church & Dwight Co. Inc. and Dealer, Inc. incorporated by reference to Exhibit 10.3 to the Company’s annual report on Form 10-K for the year ended December 31, 2016 . The Company has amended its Executive Deferred Compensation Plan II, effective as of June 1, 1997 .\n The Church & Dwight Co. Inc. Executive Deferred Compensation Plan II, amended and restated as of January 1, 2012, incorporated by reference to Exhibit 10.5 to the Company’s annual report on Form 10-K for the year ended December 31, 2011 . The company amended its compensation plan for directors effective as of May 1, 2008 .\n The Church & Dwight Co. Inc. Stock Award Plan as amended, incorporated by reference to Exhibit 10 to the Company’s quarterly report on Form 10-Q for the quarter ended June 29, 2007 . The Stock Option Plan for Directors, effective as of January 1, 1991, incorporated . The Church and Dwight Co., Inc. Amended and Restated Omnibus Equity Compensation Plan .\n Church & Dwight Co., Inc. Amended and Restated Omnibus Equity Compensation Plan, incorporated by reference to Exhibit 10.12.2 to the Company’s annual report on Form 10-K for the year ended December 31, 2021 . The Church and Dwight Co. s Under the Church . Inc., Amended .\n The Company’s current report on Form 8-K filed on February 6, 2023. orporated by reference to Exhibit 10.1 to the Company‘s quarterly report on . Form 10-Q filed on May 2, 2024. The company‘�Perform of Performance Stock Unit Grant Agreement, for Directors, incorporated by reference .\n An amended and Restated Change in Control and Severance Agreement entered into by and between the Company and Matthew T. Farrell, incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed on February 2, 2016 . An offer letter between Church & Dwight Co., Inc. and Carlos Ruiz Rabago. nd.\n The Chief Financial Officer of the Company was designated as a Registered Public Accounting Firm. The Chief Executive Officer is entitled to be a registered public accounting firm. The CFO has been designated a ‘Chief Financial Officer’ of the company’s annual report on Form 10-K for the year ended December 31, 2023. An instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline X BRL document .\n The Registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 13, 2025 . Matthew T. Farrell, President and Chief Executive Officer, signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated .\n The CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES. (Dollars in millions) For each of the three years in the period ended December 31, 2024. The CHEDULE II - Valuation and Qualifying Accounts. The Church & Dwight Co., Inc. and Subsidiaries.\n The chart shows how the country's income tax rates are based on the current amount of tax receipts and reserves . The tax rate is based on a simple formula: $1,000-a-year-fixed-rate-rate . The national income tax rate rate is $100,000 less than the current rate rate of $200,000 per year ."
}